[HTML][HTML] A unique panel of patient-derived cutaneous squamous cell carcinoma cell lines provides a preclinical pathway for therapeutic testing
S Hassan, KJ Purdie, J Wang, CA Harwood… - International Journal of …, 2019 - mdpi.com
Background: Cutaneous squamous cell carcinoma (cSCC) incidence continues to rise with
increasing morbidity and mortality, with limited treatment options for advanced disease …
increasing morbidity and mortality, with limited treatment options for advanced disease …
[HTML][HTML] Copy number rather than epigenetic alterations are the major dictator of imprinted methylation in tumors
A Martin-Trujillo, E Vidal… - Nature …, 2017 - nature.com
It has been postulated that imprinting aberrations are common in tumors. To understand the
role of imprinting in cancer, we have characterized copy-number and methylation in over …
role of imprinting in cancer, we have characterized copy-number and methylation in over …
[HTML][HTML] Haplotype-Based Noninvasive Prenatal Diagnosis of 21 Families With Duchenne Muscular Dystrophy: Real-World Clinical Data in China
L Kong, S Li, Z Zhao, J Feng, G Chen, L Liu… - Frontiers in …, 2021 - frontiersin.org
Noninvasive prenatal diagnosis (NIPD) of single-gene disorders has recently become the
focus of clinical laboratories. However, reports on the clinical application of NIPD of …
focus of clinical laboratories. However, reports on the clinical application of NIPD of …
Many private mutations originate from the first few divisions of a human colorectal adenoma
Intratumoural mutational heterogeneity (ITH) or the presence of different private mutations in
different parts of the same tumour is commonly observed in human tumours. The …
different parts of the same tumour is commonly observed in human tumours. The …
Performance evaluation of DNA copy number segmentation methods
A number of bioinformatic or biostatistical methods are available for analyzing DNA copy
number profiles measured from microarray or sequencing technologies. In the absence of …
number profiles measured from microarray or sequencing technologies. In the absence of …
[HTML][HTML] TumorNext-Lynch-MMR: a comprehensive next generation sequencing assay for the detection of germline and somatic mutations in genes associated with …
The current algorithm for Lynch syndrome diagnosis is highly complex with multiple steps
which can result in an extended time to diagnosis while depleting precious tumor …
which can result in an extended time to diagnosis while depleting precious tumor …
Allelic loss of 9p21. 3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas
Objectives: We aimed to study the potential clinical relevance of 9p allelic loss, with or
without copy number variation, in 1p/19q codeleted anaplastic oligodendroglial tumors …
without copy number variation, in 1p/19q codeleted anaplastic oligodendroglial tumors …
Chromosomal instability analysis and regional tumor heterogeneity in colon cancer
Chromosomal instability (CIN) is classically defined as an increase in the rate at which
numerical or structural chromosomal aberrations are acquired in a cancer cell. The number …
numerical or structural chromosomal aberrations are acquired in a cancer cell. The number …
[HTML][HTML] Novel variants identified with next-generation sequencing in Polish patients with cone-rod dystrophy
A Wawrocka, A Skorczyk-Werner, K Wicher… - Molecular …, 2018 - ncbi.nlm.nih.gov
Purpose The aim of this study was to identify the molecular genetic basis of cone-rod
dystrophy in 18 unrelated families of Polish origin. Cone-rod dystrophy is one of the …
dystrophy in 18 unrelated families of Polish origin. Cone-rod dystrophy is one of the …
[HTML][HTML] Gliosarcoma is driven by alterations in PI3K/Akt, RAS/MAPK pathways and characterized by collagen gene expression signature
Gliosarcoma is a very rare brain tumor reported to be a variant of glioblastoma (GBM), IDH-
wildtype. While differences in molecular and histological features between gliosarcoma and …
wildtype. While differences in molecular and histological features between gliosarcoma and …